Skip to content

Effect of Dissecting of The Inferior Pulmonary Ligament on Postoperative Pulmonary Reexpansion and Recurrence

Effect of Dissecting of The Inferior Pulmonary Ligament on Postoperative Pulmonary Reexpansion and Recurrence After Operation by Video-assisted Thoracic Surgery in the Treatment of Primary Spontaneous Pneumothorax(PSP)

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02558608
Enrollment
260
Registered
2015-09-24
Start date
2015-06-30
Completion date
2020-04-30
Last updated
2015-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumothorax

Keywords

Prime Spontaneous Pneumothorax, recurrence

Brief summary

This subject analysis of the influence of the dissociating inferior pulmonary ligament on pulmonary reexpansion and recurrence in the treatment of primary spontaneous pneumothorax by video assisted thoracic surgery. All patients are randomly divided into two groups: group A and group B. Wedge resection(WR) will be performed for all patients. Investigators dissect the inferior pulmonary ligament(DIPL) for group A. Investigators do not dissect the inferior pulmonary ligament for group B. The pulmonary reexpansion and recurrence rate are observed between the two groups.

Detailed description

Wedge resection of the lung is usually used in the treatment of primary spontaneous pneumothorax. And the pleural treatment also might be used. But part of secondary pneumothorax patients who had undergone surgical, the bullae can be found especially in the apical of lung, even if the pleural have been treated in some way.This subject provides a new way of thinking and method to solve the problem of recurrent spontaneous pneumothorax.

Interventions

PROCEDUREDIPL

dissection of the inferior pulmonary ligament

PROCEDUREWR

wedge resection of the lung bleb

PROCEDUREthoracoscopic surgery

surgery performed by video assisted thoracoscopy

Sponsors

Chinese Medical Association
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. The patients diagnosis pneumothorax with chest radiograph or computed tomography (CT) 2. The clinical and final pathological diagnosis for patient is PSP. 3. The patients with stable vital signs, no contraindication for operation and no communication barriers. 4. The patients,after informed of test content, significance and risk, who voluntarily enroll and sign informed consent.

Exclusion criteria

1. The patients who refuse to do a video assisted thoracic surgery. 2. The patients with pneumothorax with specific causes such as pulmonary hamartoangiomyomatosis, catamenial pneumothorax, and pneumothorax secondary to chronic obstructive pulmonary disease. 3. The patients who were older than 50 years 4. The patients with familial history of pneumothorax. 5. The patients with mental disorders, low Intelligence Quotient, can not objectively reflect the indicators of observation. 6. The patients who refuse to follow-up.

Design outcomes

Primary

MeasureTime frameDescription
recurrence rate3 yearsthe 3- year recurrence rate of pneumothorax after surgery.

Secondary

MeasureTime frameDescription
pulmonary reexpansion rate1 day and 4 daysthe proportion of pulmonary reexpansion on the first and fourth day after operation.

Countries

China

Contacts

Primary ContactJian Cui, director
cuijiandoctor@sina.com+861082693152

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026